Clinical Trial Update: Efficacy and Safety Evaluation of PLB1004 in Patients With Non-squamous NSCLC Harboring EGFR Exon 20 Insertion. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of PLB1004 in non-squamous non-small cell lung cancer with EGFR exon 20 insertion; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PLB1004

Snippet

Sponsor: Avistone Biotechnology Co., Ltd. | Conditions: Non-Small-Cell Lung Cancer | Phase 3 | Status: ENROLLING_BY_INVITATION